Amicus Therapeutics, Inc. Management Discusses Q2 2013 Results (Webcast)

Aug. 7.13 | About: Amicus Therapeutics, (FOLD)

Amicus Theraputics (FOLD): Q2 EPS of -$0.31 beats by $0.04. (PR)

The following audio is from an earnings conference call that will begin on August 7, 2013, at 5:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.